Clinical-stage Biotech
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both psychiatric and neurological disorders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 21, 2022 | Seed | — | 1 | CQY Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CQY Capital | Yes | Seed |